Pharmaceutical Analysis & Statistics in Oceania Countries, July 2014 (p3)

61-90 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand

Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand

  • $ 1 064
  • Industry report
  • July 2014
  • by Euromonitor International

Consumer demand for seasonal cold/flu ailments kept cough, cold and allergy (hay fever) remedies buoyant during 2013. Products are available throughout the year, but are most likely to be purchased during ...

  • Industries : Drug and Medication, Healthcare
  • Countries : New Zealand
Pharmacybrands Ltd in Consumer Health (New Zealand)

Pharmacybrands Ltd in Consumer Health (New Zealand)

  • $ 153
  • Company report
  • July 2014
  • by Euromonitor International

Pharmacybrands Ltd is expected to continue expanding its retail network of chemists/pharmacies across New Zealand through its five banners; Amcal, Care Chemist, Radius Pharmacy, Life Pharmacy and Unichem. ...

  • Countries : New Zealand
Consumer Health in New Zealand

Consumer Health in New Zealand

  • $ 2 826
  • Industry report
  • July 2014
  • by Euromonitor International

Over 2013, value sales of consumer health in New Zealand grew as a result of growing consumer confidence, which was boosted by the genesis of the Christchurch rebuild, as New Zealand’s economy finally ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Vitamins and Dietary Supplements in New Zealand

Vitamins and Dietary Supplements in New Zealand

  • $ 1 064
  • Industry report
  • July 2014
  • by Euromonitor International

Vitamins and dietary supplements remained important within New Zealand during 2013 as consumers continued to be concerned with health and wellness issues. Consumers continued to shift towards prevention, ...

  • Industries : Vitamin and Supplement, Vitamin and Supplement
  • Countries : New Zealand
Pain Medication OTC Manufacturing in Australia - Industry Market Research Report

Pain Medication OTC Manufacturing in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • June 2014
  • by Ibisworld

Growth pains: Tighter regulatory controls constrain industry revenue growth Pain Medication OTC Manufacturing in Australia Companies in this industry research and develop over-the-counter pain relief ...

  • Industries : Drug and Medication
  • Countries : Australia
QRxPharma Limited - Product Pipeline Review - 2014

QRxPharma Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

QRxPharma Limited - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘QRxPharma Limited - Product Pipeline Review - 2014’, provides an overview of the QRxPharma Limited’s pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : China, World, Australia
Australian Pharmaceutical Industries Ltd in Beauty and Personal Care (Australia)

Australian Pharmaceutical Industries Ltd in Beauty and Personal Care (Australia)

  • $ 153
  • Company report
  • June 2014
  • by Euromonitor International

Australian Pharmaceutical Industries Ltd’s strategy involves the rapid expansion of its Priceline Pharmacy portfolio of stores while maintaining its strong position in the community pharmacy wholesale ...

  • Industries : Pharmaceutical
  • Countries : Australia
Global Skincare Market: Merger and Acquisitions May 2014

Global Skincare Market: Merger and Acquisitions May 2014

  • $ 295
  • Industry report
  • June 2014
  • by Canadean Ltd

Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global skincare market during May 2014. Summary Using ...

  • Industries : Skin Care
  • Countries : United States, New Zealand, World
Physiotherapy Services in Australia - Industry Market Research Report

Physiotherapy Services in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • June 2014
  • by Ibisworld

Picture of health: An ageing population and specialisation trends support revenue growth Physiotherapy Services in Australia This industry is made up of companies and practitioners that primarily provide ...

  • Industries : Therapy
  • Countries : Australia
Sigma Pharmaceuticals Ltd in Retailing (Australia)

Sigma Pharmaceuticals Ltd in Retailing (Australia)

  • $ 153
  • Company report
  • June 2014
  • by Euromonitor International

After a successful redefinition of its business strategy, Sigma Pharmaceuticals has been focusing on strengthening its pharmacy-based retail business. In the first quarter of 2013, Sigma Pharmaceuticals ...

  • Industries : Pharmaceutical
  • Countries : Australia
PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market ...

  • Industries : Drug and Medication
  • Countries : Australia
Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication
  • Countries : World, Australia
Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication, Pathology
  • Countries : World, Australia
Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication, Pathology
  • Countries : World, Australia, Japan
Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication
  • Countries : World, Australia
Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Drug and Medication
  • Countries : World, Australia, Japan
Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Drug and Medication
  • Countries : Australia, World
Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World, Australia
Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Drug and Medication
  • Countries : World, Australia
Wheelchair Market in Thailand to 2018 - Market Size, Trends, and Forecasts

Wheelchair Market in Thailand to 2018 - Market Size, Trends, and Forecasts

  • $ 652
  • Industry report
  • May 2014
  • by Global Research & Data Services Oy

This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for wheelchairs in Thailand. The research includes historic market data from 2007 to ...

  • Industries : Vitamin and Supplement, Vitamin and Supplement, Functional Food, Pharmaceutical
  • Countries : Australia, Oceania
Australia Cardiac Rhythm Management Market Outlook to 2020

Australia Cardiac Rhythm Management Market Outlook to 2020

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Australia Cardiac Rhythm Management Market Outlook to 2020 Summary GlobalData’s new report, "Australia Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the Australia Cardiac ...

  • Industries : Cardiovascular Devices
  • Countries : Australia
Progen Pharmaceuticals Limited (PGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Progen Pharmaceuticals Limited (PGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Progen Pharmaceuticals Limited (Progen Pharmaceuticals) is a biotechnology company. It is involved in the discovery and development of cancer therapeutics. The company focuses on the development ...

  • Industries : Pharmaceutical
  • Countries : Australia, World
New Zealand Pharmaceuticals Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

New Zealand Pharmaceuticals Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary New Zealand Pharmaceuticals Ltd. (NZ Pharma) is a biotechnology service provider. The company extracts and purifies biochemicals from by-products of the New Zealand meat processing industry. Its ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Phosphagenics Limited : Ingredients - Company Profile, SWOT and Financial Report

Phosphagenics Limited : Ingredients - Company Profile, SWOT and Financial Report

  • $ 125
  • Company report
  • May 2014
  • by Canadean Ltd

Synopsis Canadean's "Phosphagenics Limited : Ingredients - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a ...

  • Industries : Drug and Medication
  • Countries : Australia, Japan

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.